TY - JOUR
T1 - Evaluating the efficacy of radically open dialectical behavior therapy (RO-DBT) in patients with anorexia nervosa :
T2 - study protocol for a randomized controlled clinical trial
AU - Avila-Parcet, Aina
AU - Martin Blanco, Ana
AU - Gawron, Leonor
AU - De la Peña-Arteaga, Víctor
AU - Carceller-Sindreu, Mar
AU - Soler, Joaquim
AU - Portella Moll, Maria J.
AU - Faustino, Gloria
AU - Cardoner, Narcís.
AU - Carmona i Farrés, Cristina
PY - 2025/4/18
Y1 - 2025/4/18
N2 - Background: Anorexia nervosa (AN) is a severe and disabling disorder, with relapse rates as high as 50% after the first episode, posing a significant challenge for clinicians. Most therapies excessively focus on nourishment, resulting in temporary weight restoration but with no improvements in general well-being and quality of life. Radically Open Dialectical Behavior Therapy (RO-DBT) is a transdiagnostic treatment designed to address overcontrol, a key aspect in the functioning of patients with AN. To date, no clinical trial (CT) has shown its efficacy in these patients or evaluated its neurobiological mechanism of action. Methods: A randomized CT in weight restored adult AN patients will be conducted, with one group receiving treatment as usual (TAU) and the other TAU plus RO-DBT, with the main outcome being quality of life. Secondary variables will include eating disorders (EDs) symptoms, overcontrol characteristics, autistic traits, and neuroimaging changes. Discussion: The results will address a gap in knowledge regarding AN treatment, with the expectation that patients receiving TAU with RO-DBT will exhibit improved quality of life and experience fewer relapses at the one-year follow-up. This is the first study examining neuroimaging changes in RO-DBT to better understand its underlying mechanisms. Trial registration: The study has been registered in ClinicalTrials.gov in September 22, 2023. It can be found in https://classic.clinicaltrials.gov/ct2/show/NCT06050421. Trial Registration Number: NCT06050421.
AB - Background: Anorexia nervosa (AN) is a severe and disabling disorder, with relapse rates as high as 50% after the first episode, posing a significant challenge for clinicians. Most therapies excessively focus on nourishment, resulting in temporary weight restoration but with no improvements in general well-being and quality of life. Radically Open Dialectical Behavior Therapy (RO-DBT) is a transdiagnostic treatment designed to address overcontrol, a key aspect in the functioning of patients with AN. To date, no clinical trial (CT) has shown its efficacy in these patients or evaluated its neurobiological mechanism of action. Methods: A randomized CT in weight restored adult AN patients will be conducted, with one group receiving treatment as usual (TAU) and the other TAU plus RO-DBT, with the main outcome being quality of life. Secondary variables will include eating disorders (EDs) symptoms, overcontrol characteristics, autistic traits, and neuroimaging changes. Discussion: The results will address a gap in knowledge regarding AN treatment, with the expectation that patients receiving TAU with RO-DBT will exhibit improved quality of life and experience fewer relapses at the one-year follow-up. This is the first study examining neuroimaging changes in RO-DBT to better understand its underlying mechanisms. Trial registration: The study has been registered in ClinicalTrials.gov in September 22, 2023. It can be found in https://classic.clinicaltrials.gov/ct2/show/NCT06050421. Trial Registration Number: NCT06050421.
KW - Anorexia nervosa
KW - Radically open dialectical behaviour therapy
KW - Neuroimaging
KW - Overcontrol
KW - Efficacy
UR - https://www.scopus.com/pages/publications/105003793064
UR - https://www.mendeley.com/catalogue/ac73b2c0-1051-3718-90a9-ac381bb6a50c/
UR - https://portalrecerca.uab.cat/en/publications/bffc0ecd-8bce-4c54-8bf8-701f0e16ae4a
U2 - 10.1186/s12888-025-06854-9
DO - 10.1186/s12888-025-06854-9
M3 - Article
C2 - 40251556
SN - 1471-244X
VL - 25
JO - BMC Psychiatry
JF - BMC Psychiatry
IS - 1
M1 - 403
ER -